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Diagnosis and treatment for coronary artery disease (CAD) often involves 2 
angiography and/or percutaneous coronary intervention. However, the radial artery 3 
catheterization required during both procedures may result in acute artery 4 
dysfunction/damage. Whilst exercise-based rehabilitation is recommended for CAD 5 
patients following catheterization, it is not known if there is a period when exercise 6 
may be detrimental due to catheter-induced damage. Animal studies have 7 
demonstrated exercise-induced paradoxical vasoconstriction post-catheterization. 8 
This study aimed to examine arterial responses to acute exercise following 9 
catheterization. Thirty-three CAD patients (65.8±7.3yr, 31.5±6.3kg.m-2, 82%♂) 10 
undergoing transradial catheterization were assessed pre- and 1 week post-11 
catheterization. Radial artery (RA) diameter and shear rate were assessed during 12 
handgrip exercise (HE), in both the catheterized (CATH) and control (CON) arms. 13 
Endothelial function was also assessed via simultaneous bilateral radial flow 14 
mediated dilation (FMD) at both time-points. We found that the increase in RA 15 
diameter and shear stress in response to HE (P<0.0001) was maintained post-16 
catheterization in both the CATH and CON arms, whereas FMD following 17 
catheterization was impaired in the CATH [6.5±3.3% to 4.7±3.5% (P=0.005)] but not 18 
in the CON [6.2±2.6% to 6.4±3.5% (P=0.797)] limb. Whilst endothelial dysfunction, 19 
assessed by FMD, was apparent 1 week post-catheterization, the ability of the RA to 20 
dilate in response to exercise was not impaired. The impact of catheterization and 21 
consequent endothelial denudation on vascular dys/function in humans may 22 
therefore be stimulus specific and a highly level of redundancy appears to exist that 23 
preserves exercise-mediated vasodilator responses.   24 
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New & Noteworthy  28 
Despite depressed flow-mediated endothelium-dependent dilation following 29 
catheterization-induced damage, radial artery responses to handgrip exercise were 30 
preserved. This suggests that arterial responses to catheterization may be stimulus 31 
specific and that redundant mechanisms may compensate for vasodilator impairment 32 
during exercise. This has implications for exercise-based rehabilitation after 33 
catheterization.  34 




Cardiovascular disease (CVD) is the leading cause of mortality worldwide (24), with 37 
coronary artery disease (CAD) the primary cause of CVD death (23). Catheterization 38 
procedures such as percutaneous transluminal coronary angiography (PTCA) and/or 39 
percutaneous coronary intervention (PCI; angioplasty), are routinely used in the 40 
diagnosis and treatment of CAD (14, 15, 26). However, such procedures are likely to 41 
mechanically damage endothelial cells (19), leading to artery dysfunction. Indeed, 42 
previous studies have reported endothelial dysfunction in both catheterized coronary 43 
(13, 28) and peripheral arteries(7, 20) following PTCA and/or PCI.  44 
 45 
Whilst exercise training is generally recommended for CAD patients (22), 46 
catheterization-induced arterial damage may transiently elevate the risk of cardiac 47 
events when the stimulus of exercise is superimposed. Indeed, previous animal 48 
studies have demonstrated that catheterization results in ‘paradoxical’ 49 
vasoconstriction of damaged arteries in response to exercise (4). If such responses 50 
are apparent in humans, there may be a basis to suggest delaying cardiac 51 
rehabilitation, post-catheterization. Although assessment of flow-mediated dilation 52 
(FMD) post-catheterization may provide useful information about arterial recovery, 53 
and therefore the safest to begin exercise rehabilitation post-catheterization, there is 54 
currently no data on the response of human arteries to exercise stimuli following 55 
catheterization-induced endothelial damage. Given the complex mechanisms by 56 
which exercise regulates blood flow (12), the vascular response of damaged arteries 57 
at rest or in response to FMD may be different from the arterial response to exercise. 58 
The aim of this study was to examine conduit arterial responses to acute exercise 59 
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pre- and post-catheterization in humans. We assessed vascular function using both 60 
flow-mediated dilation (FMD) and handgrip exercise (HE), pre- and post-61 
catheterization. Additional vascular parameters, such as blood velocity, blood flow, 62 
shear rate (mean, anterograde and retrograde), as well as blood pressure, handgrip 63 
strength and rating of perceived exertion (RPE), were secondary outcomes. We 64 
hypothesized that vascular function, assessed via FMD and the response to HE, 65 
would be impaired 1 week following PTCA and/or PCI in the catheterized arm, but 66 
not in the contralateral control artery. 67 
 68 
 69 
Materials and methods 70 
Participants and Ethical Approval 71 
Thirty-three patients undergoing prospective transradial cardiac catheterization 72 
(PTCA and/or PCI) for known or suspected CAD were recruited from Liverpool Heart 73 
and Chest Hospital (LHCH). Patients gave written informed consent. Patients were 74 
excluded if they had a recent acute coronary syndrome or transradial cardiac 75 
catheterization within the last 3 months. This study conformed to the Declaration of 76 
Helsinki, and ethical approval was obtained from the Liverpool East NHS Research 77 
Ethics Committee (REC 13/NW/0088). 78 
 79 
Study design 80 
Vascular function measurements were assessed prior to, and 1 week post-81 
catheterization (PTCA and/or PCI). Both experimental visits were completed in a 82 
quiet room, between 0800 and 1100 hrs and patients were fasted (including caffeine 83 
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and alcohol) and asked to abstain from exercise and cigarettes for 12 hours before 84 
each visit (37). Diabetic patients had a standardised breakfast (porridge or plan 85 
toast), which was the same on both occasions. The pre-assessment was undertaken 86 
on the day of the prospective catheterization, before the intervention (~1-4 hours). 87 
Experimental visits included two tests (bilateral radial artery FMD and bilateral HE), 88 
undertaken in both the catheterized (CATH) and the contralateral (CON) arm. 89 
 90 
Transradial Cardiac Catheterization 91 
PTCA and/or PCI was performed predominantly via the right radial artery (RA) (9% 92 
via left radial artery). Local anaesthesia was achieved with 2% lignocaine (Antigen 93 
Pharmaceuticals, Ireland). The RA was punctured with a 21-gauge needle through 94 
which a 0.0118” platinum-tipped nitinol guide wire was introduced. Then, a 5F (4 95 
patients), 6F (28 patients) or 7F (1 patient) hydrophilic sheath introducer (sheath 96 
length 16 cm) was inserted (PreludeEase, MeritMedical, UK). A weight-adjusted 97 
dose of heparin and routine use of vasodilator cocktail (nitroglycerine, verapamil, or 98 
diltiazem) was introduced into the central circulation during the procedure, as 99 
required. All introducer sheaths were removed at the end of the procedure and 100 
haemostasis was achieved in the catheterization laboratory through a compression 101 
device (MedPlus, UK). The patients were mobilized immediately but remained in the 102 
hospital until the compression device was removed (after ~4 hours). 103 
 104 
Experimental procedures 105 
Maximal voluntary contraction (MVC) of both arms was measured, during both visits, 106 
using a dynamometer (Takei 5420 Grip-D Digital Hand Grip Dynamometer, Japan). 107 
Patients then rested in the supine position for >10 min to ensure that all 108 
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hemodynamic variables stabilised. Blood pressure (BP) and heart rate (HR) were 109 
measured using an automated sphygmomanometer (GE Pro 300V2, Dinamap, 110 
Tampa, FL, USA), after the resting period. Two 12-MHz multi-frequency linear array 111 
probes, attached to two high-resolution ultrasound machines (T3000 or Terason u-112 
smart 3300; Teratech, Burlington, MA, USA) were used to image the RA (10-15 cm 113 
proximal from the scaphoid bone in the wrist), for both tests. Once optimal images 114 
ware obtained, the probes were held stable and the ultrasound parameters were set 115 
to optimize the longitudinal, B-mode image of the lumen–arterial wall interface. 116 
Continuous Doppler velocity assessments were obtained using the ultrasounds 117 
(insonation angle < 60°). The same ultrasounds and sonographers were used 118 
between the visits, and within participants.  119 
 120 
Bilateral radial artery FMD 121 
Both arms were extended ~45° from the torso, and two inflation/deflation pneumatic 122 
cuffs (D.E. Hokanson, Bellevue, WA) were placed proximal to the wrists (~1 cm 123 
proximal from the scaphoid bone) to provide a stimulus for ischemia. The RA in both 124 
wrists (10-15 cm proximal from the scaphoid bone in the wrist) was scanned for 1 125 
minute to obtain baseline parameters. Then, the forearm cuffs were inflated 126 
(≥220mmHg) for 5min. Diameter and velocity recordings resumed 30s prior to cuff 127 
deflation and continued for 3min thereafter, in accordance with guidelines (36, 37).  128 
 129 
Bilateral HE 130 
Following the FMD test described above, patients performed an incremental 131 
handgrip exercise (HE) protocol, while in the seated position. Participants completed 132 
3 min of HE at each of 5, 10 and 15% pre-determined MVC, with 1-min rest between 133 
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these bouts. An metronome (Korg MA30 Metronome 2006, Japan), was used to 134 
keep constant pace for the handgrip exercise HE (30 contractions per min). Diameter 135 
and velocity recordings were obtained from the RA, before the HE, and three times 136 
during the 1-min rest at the end of each HE intensity (at 5% MVC, 10% MVC and 137 
15% MVC). Rating of perceived exertion (RPE) on a 1-10 scale (1: no effort to 10: 138 
maximal effort) was taken at the end of each HE bout. 139 
 140 
Data analysis 141 
Custom-designed edge-detection and wall-tracking software was used to analyse 142 
both the FMD and HE, in order to minimise the investigator bias (36, 40). Blood flow 143 
was calculated as the product of synchronized diameter (CSA) and velocity data, at 144 
30Hz. Shear rate (SR) (an estimate of shear stress without viscosity) was calculated 145 
as four times mean velocity/diameter. FMD was reported as the percentage 146 
difference in diameter from baseline to peak, following cuff release (36). Other 147 
parameters measured during FMD, such as SRAUC (shear rate area under the 148 
curve) and time to peak dilation, were calculated from the point of cuff release to the 149 
point of maximal post-deflation diameter.  150 
 151 
For HE, changes in diameter, velocity, blood flow AUC (mean, anterograde, and 152 
retrograde), and SRAUC (mean, anterograde and retrograde) were calculated as 153 
averages (usually a 1-minute recording), before, and during the 1-min rest between 154 
the incremental HE bouts. For further analysis of HE parameters, baseline values 155 
taken before HE (Pre-Ex) and the peak value achieved (Peak-Ex) during HE (either 156 




All analyses were performed using IBM SPSS statistics for Windows, version 25.0 159 
(Armonk, NY: IBM Corp.). For FMD, allometric scaling was performed to control for 160 
differences in baseline diameter (2) and then a mixed-linear model (arm*time), 161 
controlling for baseline diameter, was undertaken. For HE, a mixed-linear model 162 
(arm*time*exercise) was used. A mixed-linear model was also used to analyze the 163 
differences in MVC, and RPE, between arms and/or pre-post catheterization. Paired 164 
t-test were used to assess BP and HR changes pre- to post-catheterization. Pairwise 165 
comparisons were performed, using the Fisher’s least significant difference (LSD), 166 
when significant main or interaction effects were detected. Data are presented as 167 




Patient characteristics and medications, prior to catheterization, are shown in Table 172 
1. The majority of the patients were taking at least one of the following: aspirin, beta-173 
blocker, angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor 174 
blocker (ARB), nitrate or a statin. All 33 patients had successful transradial 175 
catheterization; 20 patients had PTCA and 13 patients PCI (1 x no stent, 9 x 1 stent, 176 
2 x 2 stents, 1 x 3 stents). Four patients were referred for coronary artery bypass 177 
graft (CABG) following the diagnostic PTCA. These patients were stable, and their 178 
CABG was scheduled more than 1 week following diagnostic PTCA, therefore 179 
patients were allowed to attend the follow-up visit 1 week post-catheterization. FMD 180 
was performed on all 33 patients, while 29 patients completed the HE protocol (2x 181 
equipment failure, 1x avoid exercise due to dizziness following FMD, 1x previous 182 
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injury to their hand). Arterial patency was not recorded immediately after 183 
catheterization, but none of the 33 patients we assessed 1 week post-catheterization 184 
using Doppler ultrasound had any apparent radial occlusion.  185 
 186 
Impact of catheterization on HE response 187 
There was a main effect of HE on RA diameter, with RA diameter increasing in 188 
response to HE (main effect of exercise, P<0.001). This exercise-induced 189 
vasodilation was similar in both arms and remained unchanged pre- and post-190 
catheterization (time*arm*exercise interaction (P=0.725). A significant finding 191 
(time*arm interaction, P<0.001) suggested that the diameter of the catheterized RA 192 
was higher 1 week post-catheterization, compared with pre-catheterization 193 
(P<0.001), whereas RA diameter was unchanged in the control RA (P=0.086) (Table 194 
2). There was no difference in percentage change in RA diameter in response to HE, 195 
pre- vs post-catheterization, in either arm (Figure 1A).  196 
 197 
There was a significant increase in mean, anterograde and retrograde shear rate in 198 
response to HE (P<0.001), but there were no differences in these responses 199 
between arms (P=0.138, P=0.098, and P=0.133 respectively), or pre- to post-200 
catheterization (P=0.121, P=0.148, and P=0.172 respectively) (Figure 2B and Table 201 
3). Similarly, blood velocity, total mean blood flow, anterograde blood flow and 202 
retrograde blood flow followed the same pattern, with significant increases in 203 
response to exercise (P<0.001), but no differences pre- to post-catheterization 204 
(P=0.274, P=0.275, P=0.286 and P=0.614 respectively) or between arms (P=0.102, 205 
P=0.157, P=0.107 and P=0.064 respectively) (Table 3).   206 
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Impact of catheterization on FMD 207 
There was a significant impact of catheterization on FMD (time*arm interaction), 208 
when controlling for baseline diameter (P=0.034), and without baseline diameter 209 
normalization (P=0.011). There was a significant reduction in FMD in the 210 
catheterized RA [6.5±3.3% to 4.7±3.5% (P=0.005)], with no change in the non-211 
catheterized RA [6.2±2.6% to 6.4±3.5% (P=0.797)] following catheterization (Figure 212 
2).  213 
 214 
As with the HE data, baseline artery diameter during the FMD test significantly 215 
differed after catheterization (significant time*arm interaction for P=0.046). When 216 
pairwise comparisons were performed, an increase in baseline diameter 1 week 217 
post-catheterization was observed in the catheterized RA, compared to pre-218 
catheterization (P=0.009). There was no change in the control RA (P=0.785). 219 
Baseline RA diameter was not different between arms before the catheterization 220 
(P=0.707) but was significantly higher in the catheterized RA compared to the control 221 
arm 1 week post-catheterization (P=0.016). There was no change in peak diameter, 222 
time to peak diameter or shear rate under the curve (SRAUC) (Table 3).  223 
 224 
Impact of catheterization on systemic haemodynamic measurements, MVC, 225 
and RPE 226 
There was no change in BP or HR pre- to post-catheterization (Table 4). MVC was 227 
higher in the catheterized arm compared with the control arm (P=0.024), during both 228 
visits. MVC was unchanged following catheterization (P=0.265; Table 4). RPE was 229 
increased with incremental HE (main effect P<0.001), but there was no effect of 230 
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catheterization (P=0.588). When pairwise comparisons were examined, RPE at 5% 231 
MVC was lower than 10% MVC (P=0.001) and 15% MVC (P<0.001), but there was 232 




This study aimed to examine the impact of catheterization on radial artery function in 237 
CAD patients. We assessed two vascular responses: a) a shear stress mediated 238 
assessment of endothelium-dependent dilation (FMD), which is largely mediated by 239 
nitric-oxide, and b) the response to handgrip exercise (HE) which represents a 240 
mechanistically complex but ecologically valid measure of vascular function. To our 241 
knowledge, this is the first study in humans to examine radial artery responses to 242 
exercise following catheterization. We observed that vasodilator responses to 243 
exercise were relatively preserved 1 week following catheterization, whereas there 244 
was evidence for impairment in FMD responses post-catheterization. These data 245 
suggest that the impact of catheterization on functional arterial responses may be 246 
stimulus specific. 247 
 248 
Our observation that RA dilation in response to exercise was not impaired 1 week 249 
post-catheterization contrasts with some previous studies in animals, which have 250 
reported a paradoxical vasoconstriction in response to exercise following endothelial 251 
denudation (4, 30). In addition, two studies in patients performing supine bicycle 252 
exercise during a follow-up PTCA reported an exercise-induced constriction in the 253 
treated vessels, at 6 months post-PCI with 1st generation (38) and at 16 months with 254 
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2nd generation drug-eluting stents (DES) (31). However, this impairment may indicate 255 
the presence of long-term complications of stenting, such as in-stent restenosis (29), 256 
rather than the effects of catheterization-induced damage per se. In addition, there 257 
were no baseline assessments in either study and it is therefore possible that 258 
impairment was the result of advanced atherosclerotic disease (9) apparent prior to 259 
catheterization. In any event, the paradoxical constriction of catheterized arteries in 260 
response to exercise reported in these studies may contribute to exercise-induced 261 
myocardial ischemia post-catheterization (4). Indeed, endothelial damage following 262 
catheterization has been proposed as a factor to take into account when considering 263 
the optimal time to begin exercise rehabilitation (39).   264 
 265 
In the present study, we assessed the short-term impact of catheterization on arterial 266 
responses to exercise, by evaluating the responses of the RA before and 1 week 267 
post-procedure, alongside a contralateral internal control. This experimental design 268 
suggests that our result, indicating preserved arterial response to exercise, is robust. 269 
Radial arteries are comparable in size and histopathology to coronaries (3). Whilst 270 
our results cannot be directly extrapolated to other arterial beds, they nonetheless 271 
suggest that conduit arteries can retain their ability to dilate in response to exercise 272 
following catheterization. This may have implications for recommendations pertaining 273 
to safe timing of the uptake of cardiac rehabilitation. Two large-scale studies 274 
conducted to determine the incidence of cardiac events induced by exercise in 275 
patients who underwent PCI, concluded that performing exercise a few days post-276 




Our exercise outcomes are informed by the fact that we also collected FMD data, 279 
relating to endothelial function. In contrast to the exercise-mediated dilation, FMD 280 
was impaired in the catheterized arm 1 week post-catheterization. There was no 281 
change in the contralateral arm, suggesting that the impact of catheterization was 282 
localised and not systemic. Our FMD findings are consistent with previous studies in 283 
humans, which have indicated an immediate (within 24h) reduction in FMD in the 284 
catheterized artery, but not in the contralateral artery, following transradial 285 
catheterization (5-8, 20, 41). Although a recent study observed impaired endothelial 286 
function 1 week post-procedure (lower FMD in the catheterized arm compared to the 287 
control arm) (19), this study did not measure change in function pre- to post-288 
procedure. Consequently, our FMD findings are the first to report direct data on local 289 
endothelial impairment 1 week following PTCA and/or PCI. FMD evaluates 290 
endothelium-dependent dilation, which is largely nitric oxide (NO)-mediated (11). It is 291 
therefore likely that PTCA and/or PCI impair NO-production in the catheterized 292 
vessels. Reduced NO-production has been associated with proliferation and 293 
migration of VSMC, as well as the activation of platelet cascades, increasing the risk 294 
for restenosis and thrombosis (17). Interestingly, some observations indicate 295 
impaired FMD in non-catheterized vessels following PCI (16, 21, 27), suggesting that 296 
the endothelial dysfunction induced by catheterization may also reflect systemic 297 
arterial dysfunction, potentially due to elevated oxidative stress, inflammation and 298 
platelet aggregation induced by invasive procedures. Importantly, here we have 299 
shown that effects remained localized to the catheterized vessels. 300 
 301 
Regulation of blood flow during exercise is complex, involving a number of 302 
mechanisms and vasoactive compounds, with multiple interactions and redundancy 303 
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(34, 35). Our finding that catheterization impaired FMD, but not HE responses, 304 
suggests that vascular responses to exercise are preserved by redundant pathways 305 
other than those purely related to NO-mediated function. In support of this notion, 306 
Padilla et al. 2006 (25) demonstrated impaired FMD, but preserved responses to 307 
handgrip exercise, in healthy subjects following a high-fat meal. Our findings 308 
regarding stimulus specific vascular changes highlight the importance of applying 309 
multiple techniques to evaluate arterial function. Indeed, previous experiments have 310 
indicated that different periods of cuff inflation induce arterial dilation via distinct 311 
pathways in humans (11). Routinely assessing vascular responses to exercise could 312 
provide an ecologically valid assessment to complement FMD measures in future 313 
studies, particularly as it is the most relevant test to provide insights regarding 314 
exercise-based rehabilitation in CAD patients following catheterization.  315 
 316 
Previous studies of the brachial artery have indicated that, as is the case for FMD 317 
responses, HE mediated arterial dilation is shear stress mediated (1, 18, 32). For 318 
example, McPhee and Pyke (2018) (18) suggested that handgrip exercise resulted in 319 
similar vasodilation induced by reactive hyperaemia (FMD) and sustained shear 320 
(HE). In contrast, there are other studies suggesting that vasodilation in response to 321 
reactive and active hyperaemia may be driven by distinct mechanisms (25). If it can 322 
be assumed that HE-mediated dilation of the radial artery is shear stress mediated, 323 
then our finding that catheterization does not impact HE responses, despite 324 
impacting radial FMD, would suggest that the stimulus specificity relates to the 325 
nature of the shear stress stimulus. Our approach utilising post-catheterization 326 
responses may provide future insight into the sensitivity of different arteries to stimuli 327 




In addition to functional impacts, we have also shown that structural changes may 330 
occur after catheterization. There was an increase in RA diameter in the catheterized 331 
arm, but not in the contralateral arm, 1 week post-catheterization. This was observed 332 
prior to both FMD and HE. Previous studies have reported similar findings of 333 
elevated RA diameter in the catheterized arm 24h post-catheterization (6-8, 41). 334 
Collectively, our findings suggest that such structural modifications remained 335 
apparent 1 week post-catheterization and therefore should be consider as a 336 
consequence of catheterization and not just an immediate reaction of the artery to 337 
the procedure. The time-course of structural adaptation or remodelling following 338 
catheterization is an important question that might be addressed in future studies. 339 
 340 
This study had a number of limitations. We did not control for age, gender, pre-341 
existing disease (diabetes, hypertension, peripheral artery disease), history of 342 
smoking or medication use (including potential changes pre- to post-intervention). 343 
However, our patient population are typical of those attending for interventions and 344 
our repeated measures study design and contralateral within-subjects control artery 345 
somewhat mitigates these limitations. In addition, we were not able to control for 346 
different introducer catheter size, or compression time, which were both clinically 347 
determined, as indicated. These may have affected arterial patency and possibly 348 
vascular outcomes. In our study, 6F introducers were mostly used (28 out of 33 349 
patients), with 5F and 7F introducers used in 4 and 1 patient, respectively. However, 350 
we performed a supplementary mix-model liner regression, for FMD and HE 351 
17 
 
responses, with catheter size as a covariate and this did not affect the study 352 
outcomes or interpretation. 353 
 354 
In conclusion, this study provides important information regarding arterial function 355 
following catheterization in humans. Our data showed that, although catheterization 356 
induced localised impairment in flow mediated dilation, the ability of the RA to dilate 357 
in response to exercise following catheterization-induced damage was largely 358 
unaffected. This highlights that vascular responses to catheterization may be 359 
stimulus specific. Since arterial responses to exercise were relatively preserved 360 
following catheterization, it may be safe to undertake exercise-based rehabilitation 361 
soon after catheterization procedures, although this should be confirmed in other 362 
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Figure 1. Vascular responses to handgrip exercise (HE).  564 
Percentage change in RA diameter following HE (A), in the catheterized RA (CATH 565 
arm) and contralateral control RA (CON arm), pre- and 1 week post-catheterization. 566 
Mean shear rate (B), prior to exercise (PreEx) and at peak (PeakEx), in the CATH 567 
arm and CON arm, pre- and 1 week post-catheterization. Results are presented as 568 
mean ± SD n=29 (24 males). *Significantly different from PreEx, main effect of 569 
exercise intensity (P<0.05). 570 
 571 
Figure 2. Changes in flow mediated dilation (FMD %) in the catheterized radial 572 
artery (CATH) and contralateral arm (CON), pre- and 1 week post-573 
catheterization.  574 
Results are presented as mean ± SD n=33 (27 males). A mix-linear model 575 
(arm*time) with Fisher’s least significant difference post hoc for pairwise 576 
comparisons was used. *Significantly different from Pre, main interaction effect of 577 




Table 1. Characteristics of the study population (n=33) 
Clinical Characteristic Mean ± SD or n (%) 
Age (years) 65.8 ± 7.3 
Sex (males) 27 (81.8) 
BMI (m/kg2) 31.5 ± 6.3 
Risk Factors Diabetes 9 (27.2) 
Hypertension 20 (60.6) 
Hypercholesterolemia  24 (72.5) 
Current smoker 3 (9.1) 
Ex-smoker 17 (51.5) 
Positive family history  20 (60.6) 
Previous transradial catheterization (PTCA and/or PCI) 20 (60.6) 
Previous CABG 0 (0) 
Previous MI > 3 months 13 (39.4) 
Medications Aspirin 29 (87.8) 
Clopidogrel 2 (6) 
Beta-Blocker 20 (60.6) 
ACEI/ARB 22 (66.7) 
Nitrate 23 (69.7) 
Statin 26 (78.8) 
Calcium-Blocker 9 (27.3) 
Diuretics 7 (21.2) 
BMI: body mass index, PTCA: percutaneous transluminal coronary angiography, PCI: 
percutaneous coronary intervention, CABG: coronary artery bypass graft, MI: 
myocardial infraction, ACEI: angiotensin-converting enzyme inhibitor; ARB: 
angiotensin receptor blocker. 
Table 2. Vascular responses to handgrip exercise (HE). Vascular parameters, at rest, 
prior HE (PreEx) and the peak value to HE (PeakEx), in the catheterized radial artery 
(CATH) and the contralateral radial artery (CON), before the catheterization (Pre) and 
at 1 week post-catheterization.  
 CATH arm CON arm 
Diameter (mm) Pre 1 week Post Pre 1 week Post 
PreEx 2.7±0.5 2.9±0.4 2.8±0.5 2.7±0.5 
PeakEx 2.9±0.5* 3.0±0.4* 2.9±0.6* 2.8±0.5* 
Velocity (cm/s)     
PreEx 6.1±4.0 5.0±3.9 6.8±6.0 6.0±4.4 
PeakEx 15.0±6.7* 13.9±7.7* 16.5±10.3* 15.8±8.8* 
Total Blood Flow (ml/min) 
PreEx 20.5±15.2 20.2±15.8 25.0±28.0 21.7±22.0 
PeakEx 54.7±25.4* 56.1±28.4* 67.7±46.6* 56.0±33.7* 
Anterograde Blood Flow (ml/min) 
PreEx 23.5±14.9 22.7±15.3 28.5±27.1 25.7±21.1 
PeakEx 54.9±24.6* 56.4±28.1* 68.1±46.2* 56.4±33.5* 
Retrograde Blood Flow (ml/min) 
PreEx -3.0±2.6 -2.4±1.8 -3.5±3.4 -4.0±5.5 
PeakEx -1.2±1.7* -1.2±1.4* -1.6±2.2* -1.0±1.3* 
Anterograde Shear rate (1/s) 
PreEx 108.1±67.3 79.5±56.5 115.0±91.1 104.7±58.4 
PeakEx 227.4±122.8* 194.9±118.9* 238.2±171.0* 232.4±130.4* 
Retrograde Shear Rate (1/s) 
PreEx -13.2±13.2 -8.7±6.9 -13.3±13.8 -15.1.2±20.5 
PeakEx -4.8±7.2* -3.5±3.6* -7.1±13.1* -3.7±5.7* 
Results are presented as mean ± SD, n=29 (24 males). A mix-linear model 
(arm*time*exercise) with Fisher’s least significant difference post hoc for pairwise 
comparisons was used. *Significantly different from PreEx, main effect of exercise 
(P<0.05) 
 
Table 3. Baseline dimeter, peak diameter, time to peak and SRAUC associated with 
the FMD tests before the procedure (Pre) and at 1 week post-catheterization, in the 
catheterized (CATH) arm and the contralateral (CON) arm. 
 CATH arm CON arm 
 Pre 1 week Post Pre 1 week Post 
Baseline diameter (mm) 2.82±0.7 3.04±0.5* 2.85±0.5 2.73±0.5† 
Peak Diameter (mm) 3.00±0.7 3.18±0.5 3.03±0.5 3.01±0.6 
Time to peak (s) 50.8±25.1 56.7±27.9 66.0±32.4 57.4±34.2 
SRAUC (s-1 103) 18.5±12.4 15.0±8.8 16.3±10.6 14.0±9.3 
SRAUC: shear rate area under the curve. Results are presented as mean ± SD, 
n=33 (27 males). A mix-linear model (arm*time) with Fisher’s least significant 
difference post hoc for pairwise comparisons was used. *Significantly different from 
Pre (P<0.05), †Significantly from CATH arm (P<0.05). 
 
 
Table 4. Resting haemodynamic measurements, MVC in the catheterised arm 



















SBP: systolic blood pressure, DPB: diastolic blood pressure, MAP: mean blood 
pressure, HR: heart rate, MVC: maximal voluntary contraction, RPE: rate of 
perceived excursion (1: no effort to 10: maximal effort). Results are presented as 
mean ± SD, n=33 (27 males). A paired t-test was used to assess BP and HR. A 
mixed-linear model was used to analyze MVC and RPE, between arms and/or pre-
post catheterization with Fisher’s least significant difference post hoc for pairwise 
comparisons (P<0.05). *Significantly different from 5% MVC, †Significantly different 
from 10% MVC, ‡Significantly different from 15% MVC. 
 Pre 1 week Post P value 
Haemodynamic measurements 
SBP (mmHg) 138±19 133±23 0.151 
DBP (mmHg) 81±10 78±10 0.121 
MAP (mmHg) 100±11 94±21 0.080 
HR (beats per min) 62±12 61±11 0.428 
MVC (Kg)    
CATH arm 32.6±9.7 33.7±9.7 0.297 
CON arm 31.2±9.5 31.8±7.9 0.592 
RPE (1-10) during incremental HE 
5% MVC 2.1±1.5†,‡ 1.7±1†,‡ 0.329 
10% MVC 3.8±2* 3.5±1.9* 0.562 
15% MVC 5.4±2.2* 5.7±2.1* 0.109 
